Results 11 to 20 of about 8,658 (209)

Successfully treated case of severe hypothermia secondary to myxedema coma

Acute Medicine & Surgery, 2023
Background Myxedema coma is an extremely rare but fatal endocrine emergency that requires urgent recognition and treatment. We describe a case of severe hypothermia that rapidly deteriorated to cardiac arrest that was attributed to myxedema coma.
Hirotsugu Yamamoto, Takashi Hongo, Tsuyoshi Nojima, Takafumi Obara, Yoshinori Kosaki, Kohei Ageta, Kohei Tsukahara, Tetsuya Yumoto, Atsunori Nakao, Hiromichi Naito   +9 more
doaj   +2 more sources

Case Report: Myxedema Coma Caused by Immunoglobulin A Vasculitis in a Patient With Severe Hypothyroidism

Frontiers in Immunology, 2022
Myxedema coma is a critical disorder with high mortality rates. Disruption of the compensatory mechanism for severe and long-term hypothyroidism by various causes leads to critical conditions, including hypothermia, respiratory failure, circulatory ...
Hiroshi Ito, Hiroshi Ito, Kenzo Fukuda, Kenzo Fukuda, Kenji Ashida, Kenji Ashida, Ayako Nagayama, Tomoki Sako, Kouichiro Mizuochi, Masaharu Kabashima, Satoko Yoshinobu, Shimpei Iwata, Nao Hasuzawa, Sumika Hayashi, Tomoyuki Akashi, Masatoshi Nomura   +15 more
doaj   +2 more sources

Myxedema Coma Complicated by Pancytopenia

Case Reports in Medicine, 2019
Hypothyroidism is common, with an extreme manifestation of myxedema coma if untreated. Hematologic consequences of myxedema coma include mild leukopenia and anemia, rarely pancytopenia.
Charles T. Mupamombe, Felix M. Reyes, Derek B. Laskar, Joseph Gorga   +3 more
doaj   +2 more sources

Myxedema Psychosis: Neuropsychiatric Manifestations and Rhabdomyolysis Unmasking Hypothyroidism

Case Reports in Psychiatry, 2020
Background. Hypothyroidism is a prevalent endocrine disorder, often presenting with a spectrum of symptoms reflecting a hypothyroid state. It is also generally linked to causing mood swings, psychomotor slowing, and fatigue; however, in rare instances ...
Sundus Sardar, Mhd-Baraa Habib, Aseel Sukik, Bashar Tanous, Sara Mohamed, Raad Tahtouh, Abdelrahman Hamad, Mouhand F. H. Mohamed   +7 more
doaj   +2 more sources

Mechanical Circulatory Support in Management of Cardiogenic Shock and Myxedema Coma

Case Reports in Cardiology, 2019
The cardiovascular system is a major target of thyroid hormone action and the two systems are closely interlinked. It can be greatly impacted even with subtle alterations in thyroid function.
Jelena Z. Arnautovic, Randi Connor-Schuler, Randy Ip   +2 more
doaj   +2 more sources

Myxedema Psychosis: Systematic Review and Pooled Analysis

Neuropsychiatric Disease and Treatment, 2021
Mouhand FH Mohamed,1,2 Mohammed Danjuma,1,3 Mohammed Mohammed,4 Samreen Mohamed,4 Martin Siepmann,5 Kristian Barlinn,6 Salah Suwileh,1 Lina Abdalla,1 Dabia Al-Mohanadi,7 Juan Carlos Silva Godínez,8,9 Abdel-Naser Elzouki,1,3 Timo Siepmann2,6 1Department ...
Mohamed MFH, Danjuma M, Mohammed M, Mohamed S, Siepmann M, Barlinn K, Suwileh S, Abdalla L, Al-Mohanadi D, Silva Godínez JC, Elzouki AN, Siepmann T   +11 more
doaj   +2 more sources

Utility of rituximab treatment for exophthalmos, myxedema, and osteoarthropathy syndrome resistant to corticosteroids due to Graves’ disease: a case report

Journal of Medical Case Reports, 2018
Background Exophthalmos, myxedema, and osteoarthropathy syndrome is a very rare condition that is associated with Graves’ disease. The presence of dermopathy and the involvement of joint/bone tissues indicate that it seems to be related with the severity
Aldo Ferreira-Hermosillo, Ruben Casados-V, Pedro Paúl-Gaytán, Victoria Mendoza-Zubieta   +3 more
doaj   +2 more sources

Nivolumab induced myxedema crisis

Journal for ImmunoTherapy of Cancer, 2017
Background Nivolumab is an anti-programmed cell death (anti-PD-1) monoclonal antibody that is approved by Food and Drug Administration for treatment of metastatic non-small cell lung cancer, metastatic melanoma, relapsed Hodgkin lymphoma and advanced ...
Uqba Khan, Humaira Rizvi, Dahlia Sano, Jane Chiu, Tarik Hadid   +4 more
doaj   +2 more sources

Sequential Amiodarone-Induced Thyroid Dysfunction: From Myxedema Coma to Late-Onset Type 1 Thyrotoxicosis After Drug Withdrawal. [PDF]

Clin Case Rep
ABSTRACT Amiodarone therapy may induce thyroid dysfunction in approximately 20% of patients, either amiodarone‐induced hypothyroidism (AIH) or thyrotoxicosis (AIT). Both situations may occur at any time during treatment or even months to years after drug withdrawal due to tissue storage with slow systemic release.
Soares DM, Ferreira L.
europepmc   +2 more sources

Rescue Mastectomy in a Patient With Locally Advanced Triple-Negative Breast Cancer and Severe Biochemical Hypothyroidism: A Multidisciplinary Ethical and Surgical Dilemma. [PDF]

Case Rep Oncol Med
Severe hypothyroidism is traditionally considered a contraindication to elective major surgery due to the risk of perioperative metabolic decompensation and myxedema coma. However, in oncologic settings, delaying surgery may result in irreversible loss of resectability and adverse outcomes.
Buelvas N.
europepmc   +2 more sources